Reference 2017-445

REF:            2017-445

Subject:        Caspofungin (Generic) and Cancidas (May 2016 – April 2017)

          

 

Request:

Under the Freedom of Information Act, I am writing to request details of the quantity of vials prescribed for below products by your Trust.

The period for which data is being requested is May 2016 – April 2017.

Data Requested for below products:

  • Caspofungin 50mg powder for concentrate for solution for infusion
  • Cancidas 50mg powder for concentrate for solution for infusion
  • Caspofungin 70mg powder for concentrate for solution for infusion
  • Cancidas 70mg powder for concentrate for solution for infusion

 

 

Response:

Number of vials used between May 2016 and April 2017 was:

 

Caspofungin 50mg – 0

Cancidas 50mg – 33

Caspofungin 70mg – 0

Cancidas 70mg – 9